All of our C-level executives have deep expertise in skin science and pharmaceutical innovation. In fact, they developed one of the world’s most respected dermatological skincare brands, SkinMedica. Together they created a team of smart, savvy and experienced women and partnered with the country’s most respected skin physicians.

This collaboration resulted in Colorescience - a truly skin-first line of prestige makeup that gives women the luxurious colors, textures, and finishes they expect from high-end cosmetics while delivering the science of healthy skin.

We believe beauty can be a healthy proposition. We know every woman, including ourselves, deserves cosmetics that beautify AND nourish AND protect, all at once, every single time. We are committed to creating a trustworthy beauty line that makes skin look gorgeous today, tomorrow and beyond.

Colorescience Corporate Team

Mary Fisher

Mary Fisher Chair & Chief Executive Officer

Mary Fisher is Chair, Chief Executive Officer and Board Director at Colorescience, a former division of SkinMedica Inc., where she served as Chief Executive Officer from 2008 until 2012. She led the successful sale of the company to Allergan, Inc. for $350 million with the potential for another $25 million contingent on certain sales milestones. Ms. Fisher has more than 30 years in the pharmaceutical and biotechnology industries, including management and leadership positions at Acorda Therapeutics, Cephalon, Immunex and Boehringer Ingelheim. She is on the board of directors of Ovascience and MDRejuvena. In 2013, Ms. Fisher was honored as Ernst & Young's Entrepreneur of the Year for San Diego and also received the EY Venture Capital Award of Excellence.

Ted Ebel

Ted Ebel Chief Business Officer

Ted Ebel serves as Chief Business Officer at Colorescience. Mr. Ebel has 20 years of experience in the health, wellness and consumer products industries. Prior to Colorescience, Mr. Ebel was Senior Vice President of Corporate Development for SkinMedica, Inc. having responsibility for mergers and acquisitions, licensing, intellectual property management, market research and establishing the company's international operations. Earlier in his career, Mr. Ebel served as the Executive Director of Corporate Development at CancerVax Corporation, a biotechnology company focused on cancer immunotherapy, and as the Vice President of Strategic Ventures for MP3.com, a publicly traded internet and entertainment company. In addition, Mr. Ebel held positions in marketing and corporate development at Amgen, Inc. and began his career as a consultant in the health care practice of the management consulting firm Arthur D. Little. Mr. Ebel received his Bachelor of Science, Magna Cum Laude, from Duke University, and his MBA from the Wharton School at the University of Pennsylvania.

Steve Loomis

Steve Loomis Chief Financial Officer

Steve Loomis joined Colorescience in May 2013 as Chief Financial Officer after three years at SkinMedica, where he served as as Senior Vice President of Finance, Chief Financial Officer and Corporate Secretary. From 1996 to February 2010, Mr. Loomis served as Vice President of Finance, Chief Financial Officer and Corporate Secretary for CardioDynamics International Corporation, a publicly traded international medical device company, and in 2008, he was appointed to the additional role of Vice President of Operations. From 1993 until 1996, he served as Director of Financial Reporting at Kinko's Inc. a worldwide business service provider. From 1988 to 1993, Mr. Loomis was Chief Financial Officer for Terminal Data Corporation, a publicly traded international high technology manufacturing company. He earned his Bachelor's degree in business administration from California State University at Northridge. Mr. Loomis is a certified public accountant and has served on the board of several for-profit and not-for-profit organizations. Mr. Loomis was awarded San Diego Business Journal's 2011 CFO of the Year.


Board of Directors

Rich Aldrich

Rich Aldrich

Mr. Aldrich is co-founder and General Partner of Longwood Fund and has spent approximately 35 years as a life sciences entrepreneur and investor. Mr. Aldrich co-founded and helped to build several successful biotech companies including Sirtris Pharmaceuticals (Nasdaq: SIRT acquired by GSK in 2008), Concert Pharmaceuticals (Nasdaq: CNCE), where he serves as Chairman of the Board, and Longwood portfolio companies Alnara Pharmaceuticals (acquired by Eli Lilly in 2010), Verastem (Nasdaq: VSTM), Flex Pharma (Nasdaq: FLKS), Axial Biotherapeutics and OvaScience (Nasdaq: OVAS), where he previously served as Chairman and now serves as Lead Director of the Board of Directors. Mr. Aldrich also serves as Chairman of the Board of Directors at Longwood portfolio company KalVista Pharmaceuticals (Nasdaq: KALV) and is a Director of Longwood portfolio companies Axial, Mitobridge, and Renovia.

Prior to co-founding Longwood, Mr. Aldrich founded RA Capital Management, LLC, a life sciences hedge fund, in which he remains an investor. Prior to founding RA Capital Management, LLC, Mr. Aldrich was a founding employee of Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), a $37 billion company, where he held the position of Senior Vice President and Chief Business Officer and managed all commercial and operating functions from 1989 to 2001. Prior to joining Vertex, Mr. Aldrich held several management positions at Biogen Inc.

Mr. Aldrich received his undergraduate degree from Boston College and an M.B.A. from the Amos Tuck School at Dartmouth College.


Josh Baltzell

Josh Baltzell

Josh Baltzell is a Managing Director with Split Rock Partners. He joined the Firm's at its inception in 2005 and provides the healthcare team with an extensive background in the medical device industry, having been involved in virtually all aspects from product development to the acquisition and sale of mature organizations.

Prior to joining Split Rock Partners, Josh served as a Principal with St. Paul Venture Capital's healthcare team, which he joined in 2002. He joined St. Paul Venture Capital from Piper Jaffray where he held the position of vice president in the healthcare investment banking group. During his tenure there, he was involved in a broad range of investment banking activities including private and public equity financings as well as mergers and acquisitions on the buy and sell side.

Prior to joining Piper Jaffray, Josh spent several years in various marketing and business development positions in the medical device industry including vice president, marketing and business development for a medical device start-up and group product manager - emerging technologies for SCIMED/Boston Scientific.

Josh graduated from St. Olaf College and has an MBA from the University of Minnesota's Carlson School of Management.


Mary Fisher

Mary Fisher

Mary Fisher is Chair, Chief Executive Officer and Board Director at Colorescience, a former division of SkinMedica Inc., where she served as Chief Executive Officer from 2008 until 2012. She led the successful sale of the company to Allergan, Inc. for $350 million with the potential for another $25 million contingent on certain sales milestones. Ms. Fisher has more than 30 years in the pharmaceutical and biotechnology industries, including management and leadership positions at Acorda Therapeutics, Cephalon, Immunex and Boehringer Ingelheim. She is on the board of directors of Ovascience and MDRejuvena. In 2013, Ms. Fisher was honored as Ernst & Young's Entrepreneur of the Year for San Diego and also received the EY Venture Capital Award of Excellence.


Nicky Kinnaird

Nicky Kinnaird

Nicky Kinnaird is a long-time, esteemed innovator in the beauty industry. She revolutionized retail beauty in the early 1990’s with the launch of Space NK Apothecary in London’s Covent Garden. The ground-breaking boutique featured a curated mix of beauty and wellbeing lines and quickly grew into an international beauty mecca—known for offering consumers a unique selection of the finest established and burgeoning brands. Having stepped down from her Space NK duties over 2 years ago, Kinnaird has fed her passion for the evolution of consumer-focused beauty by consulting on growing brands.


Adele Oliva

Adele Oliva

Adele Oliva brings decades of finance and healthcare experience to 1315 Capital, including 20 years in private equity focused on commercial stage specialty pharmaceutical, medical technology, and healthcare service investments.

Adele co-founded 1315 Capital in 2015 to establish a firm focused on healthcare growth investing. She was recruited to Quaker Partners in 2007 to expand their growth stage investing practice. Prior to Quaker, Adele was Co-Head of US Healthcare at Apax Partners, where she started in 1997.

Forbes recognized Adele on its Midas List of top 100 technology investors worldwide, top 10 life science investors and top women in venture capital.

Adele has served on the board of Ascent Healthcare Solutions (acquired by Stryker), EKR Therapeutics (acquired by Cornerstone Therapeutics), ESP Pharma (acquired by Protein Design Labs), Esprit Pharma (acquired by Allergan), Precision Dermatology (acquired by Valeant), Prometheus Labs (acquired by Nestle) and SkinMedica (acquired by Allergan). She currently serves on the boards of Colorescience, Genoptix, Innovative Health, NovaSom, Onkos Surgical, and TELA Bio.

Prior to entering private equity as a Kauffman Fellow, Adele held roles at CoreStates in commercial banking and Baxter Healthcare in marketing and business development.

Adele received a BSc from St. Joseph’s University and an MBA from Cornell University, where she was awarded the Albert Fried Fellowship.


David Olsen

David Olsen

David Olsen is the Chief Executive Officer (CEO) of Cos Bar, the original 40-year-old specialty beauty retailer in the U.S. Cos Bar is recognized for disrupting the luxury beauty industry with its unique and engaging sales experience focused on the needs of the client and its carefully curated array of the world’s best beauty brands.

Since joining in February 2016, David has worked to grow the company while maintaining a commitment to delivering a seamless omnichannel experience for clients, wherever they are and whichever device they are on. In his short tenure, David’s team opened 6 stores, bringing the total store count to 20; opened corporate headquarters in Los Angeles; refreshed the brand identity and store environment; relaunched cosbar.com; and introduced Cos Bar’s first loyalty rewards program, B. Cos. With David’s guidance, Cos Bar will operate 50 doors nationwide by 2021.

David has been in the retail space as a strategist and operator for over 17 years. Prior to joining Cos Bar, he was the global vice president of Beauty and Grooming at The Net-A-Porter Group, where he developed and executed that strategy from 2012 to 2016. In 2000, David started his own e-commerce cosmeceutical business which was later sold to DermStore.com, leading to the creation of the largest pure play beauty destination in the US, ultimately selling to Target. David brings his digital expertise and growth focus to Cos Bar to ensure the execution of their mission to deliver the world’s best luxury beauty buying experience.


Ty Stiklorius

Ty Stiklorius

Ty Stiklorius is the Founder and CEO of Friends At Work, an entertainment, media and impact agency that partners with the world’s greatest artists and thinkers. Ty launched FAW in 2015 and manages a diverse roster of artists and influencers including John Legend, Ciara, Lindsey Stirling, Rooty, Cynthia Erivo, Madame Gandhi and ItsTheReal.

Alongside Legend and Mike Jackson, Ty is also one of the principals of Get Lifted Film Co., a film and TV production company based in Los Angeles. Under the Get Lifted, banner, the trio has served as Executive Producers on the HBO documentary “Southern Rites,” WGN’s hit series “Underground” and the award-winning film “La La Land.”

Ty’s work with John Legend began with the formation of JL Ventures in 2006, where she created strategies for innovation, business development and social impact built on the artist’s unique vision and desire to do good in the world. From there, they launched The Show Me Campaign, with a mission to give every child access to a quality education. In 2015, Ty and Legend started the #FREEAMERICA campaign to shift the national conversation around our country’s misguided incarceration policies. Ty is also co-founder of Prosecutor Impact, which works to highlight the power of the prosecutor to shape outcomes in the criminal justice system.

Ty earned an MBA from The Wharton School of Business as well as a BA from The University of Pennsylvania. She serves on the board of LIFT Communities, a national non-profit dedicated to helping families break the cycle of poverty. Ty is also on the board of LRNG, a social enterprise that works with schools, businesses, and cities and community institutions to redesign learning so all youth have the opportunity to succeed.